Armstrong's Sixth Tour Victory in a Doping-Tainted Era
The 2004 Tour de France saw Lance Armstrong claim his sixth consecutive yellow jersey, dominating a three-week battle that would be decided through Armstrong's consistent superiority in the mountains and his team's tactical organization. Armstrong defeated Andreas Klöden of Telekom by a substantial margin, with Ivan Basso rounding out the top three. Yet like the Tours before and after it, the 2004 edition would later be revealed as deeply compromised by systematic doping among its top contenders. No official winner exists for the 2004 Tour de France following Armstrong's 2012 stripping.
Armstrong approached the 2004 Tour as the clear favorite, a role he had inhabited since his return to professional cycling in 1999. The Discovery Channel team had been built around him with meticulous care, recruiting strong domestiques and experienced climbers whose primary role was supporting Armstrong's assault on the Tour's mountains. The team's tactical discipline and superior strength meant that Armstrong could ride conservatively during neutral stages and save his energy for the decisive mountain phases.
Klöden, who would finish second, proved to be Armstrong's closest challenger, though the gap between them told the story of the race. Armstrong's margin of victory over the German rider was decisive, suggesting a level of superiority that spoke to the effectiveness of Armstrong's preparation and training regime. Jan Ullrich, once Armstrong's great rival, finished fourth, a full 8 minutes and 50 seconds adrift, indicating that Armstrong's dominance extended even to the era's other strongest climbers.
Ivan Basso's third-place finish marked him as one of the rising talents in professional cycling, a climber of genuine class who would mount serious challenges to Armstrong in future Tours. At the time, Basso appeared to be the heir apparent to cycling's mountain throne, a young rider with the gifts to potentially dominate the sport in the coming years. Yet Basso, too, would later face accusations of doping that would color his legacy and cast shadows over his performances.
The 2004 Tour was decided through Armstrong's performances in the mountains, where he demonstrated climbing ability that seemed to transcend the normal parameters of human performance at altitude. His attacks were decisive, his recoveries remarkable, and his ability to control the race from the front was complete. The American rode with confidence and authority, managing the psychological aspect of the Tour with the maturity of a five-time champion.
Klöden, who would finish second ahead of Basso, faced his own doping questions years later. An independent investigation found evidence that Klöden had received a blood transfusion at Freiburg University Clinic during the 2006 Tour de France, raising questions about his practices throughout his career. Like many of his contemporaries, Klöden's achievements would be shadowed by questions of chemical enhancement.
The systematic doping that characterized the 2004 Tour—and indeed, the entire era from 1999 to 2005—was only fully revealed years later through investigations by USADA and other anti-doping agencies. When Armstrong was finally stripped of his victories in 2012, the 2004 Tour became another race without an official winner, another monument to an era when professional cycling had been thoroughly corrupted by chemical enhancement at the sport's highest levels.
The racing that unfolded across the 2004 Tour's mountains was genuine—the suffering was real, the tactical battles were fought with intelligence and courage. Yet that racing took place against a backdrop of systematic doping that undermined its legitimacy and integrity. The 2004 Tour de France thus stands as another chapter in an era that would eventually come to represent professional cycling's greatest shame, a race contested among riders whose enhanced performances could not be distinguished from natural ability, and decided by a champion whose entire legacy would be rendered fraudulent by revelation.